Clinical Trial Update: Study on Ketorolac for Improving Outcomes and Prognosis in Patients With Stanford Type A Aortic Dissection [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating ketorolac for improving outcomes and prognosis in patients with Stanford type A aortic dissection; recruitment is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Dissection

Drugs mentioned

• Ketorolac (Ketorolac tromethamine)

Snippet

Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Conditions: Aortic Dissection, Inflammation | Phase 3 | Status: RECRUITING